India-based healthcare technology provider CitiusTech has launched an AI solution focused on ensuring quality and trust in genAI applications in healthcare. The software offers automated validation and monitoring of over 70 metrics across seven dimensions. CitiusTech claims that 80% of genAI initiatives face delays due to reliability and compliance concerns. The company aims to seamlessly integrate this capability into its solutions to enable clients to confidently scale genAI-powered solutions. The adoption of genAI in healthcare in the Asia-Pacific region is expected to be cautious due to safety and effectiveness concerns, but some institutions like China Medical University Hospital and Synapxe in Singapore are already leveraging genAI for precision cancer treatment and predictive tool enhancement.
Source link
Industry-first quality solution for scaling genAI adoption
